雜志介紹

Translational Cancer Research雜志介紹

《Translational Cancer Research》是一本以English為主的未開放獲取國際優秀期刊，中文名稱轉化癌癥研究，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.5，最新CiteScore 指數為2.1。

本刊近期中國學者發表的論文主要有：

• Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer

  Author: Zheng, Mengmeng; Wu, Linfeng; Xiao, Rongyao; Zhou, Yuying; Cai, Jiaohao; Chen, Weike; Chen, Chao; Sun, Kaiting; Shen, Shurong

• Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia

  Author: Zhang, Tong; Liao, Danying; Hu, Yu

• Surgical resection of primary tumors improves survival in patients with lung metastases: a population-based SEER analysis

  Author: Liu, Tianyu; Lv, Xiaolong; Yang, Lei; Yang, Zelin; Jia, Chenhao; Chen, Huanwen

• Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study

  Author: Song, Ying; Wang, Jinlu; Wang, Xiuli; Li, Rui; Niu, Xingjian; Yang, Yue; Yang, Xudong; Yin, Lei; Wang, Yiran; Zhang, Han; Shui, Ruixue; Zhang, Cuiying; An, Jing

英文介紹

Translational Cancer Research雜志英文介紹

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.